Andrx and Watson reach agreement to merge

Article

Andrx Corp. and Watson Pharmaceuticals have signed a definitive merger agreement providing for the acquisition of Andrx by Watson. Dates for closing the acquisition have not yet been determined.

Andrx and Watson reach agreement to merge

Andrx Corp. and Watson Pharmaceuticals have signed a definitive merger agreement providing for the acquisition of Andrx by Watson. Dates for closing the acquisition have not yet been determined.

To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.

Recent Videos
Related Content
NCPA's New Consortium Exemplifies Preparedness in Community Pharmacy

NCPA's New Consortium Exemplifies Preparedness in Community Pharmacy

Brian Nowosielski;Kurt Proctor, PhD, RPh
January 23rd 2025
Article

The new initiative is a way for NCPA to proactively engage its network of community pharmacies during a potential public health crisis.

American Pharmacies: Powering the Profession Through Leadership

American Pharmacies: Powering the Profession Through Leadership

Brian Nowosielski
December 3rd 2024
Podcast

Drug Topics sat down with Laird Leavoy, President of American Pharmacies, to discuss the role leadership plays in the independent pharmacy industry.

Nonopioid Therapy Shown to Significantly Reduce Pain Intensity in Phase 3 Trial

Nonopioid Therapy Shown to Significantly Reduce Pain Intensity in Phase 3 Trial

Killian Meara
January 23rd 2025
Article

Cebranopadol is a first-in-class investigational therapy that targets the nociceptin/orphanin FQ receptor and the µ-opioid receptor.

How Centralized Fulfillment is Making Pharmacy More Efficient

How Centralized Fulfillment is Making Pharmacy More Efficient

Brian Nowosielski
November 25th 2024
Podcast

Tom Utech, PharmD, CEO of iA, joined Drug Topics to discuss his company’s centralized pharmacy fulfillment solutions.

Q&A: Ultra-High-Cost Drugs Highlight Complex US Health Care System

Q&A: Ultra-High-Cost Drugs Highlight Complex US Health Care System

Brian Nowosielski;Erin R. Fox, PharmD, MHA, BCPS, FASHP
January 22nd 2025
Article

Erin Fox, PharmD, MHA, BCPS, FASHP, discussed the 2025 Pharmacy Forecast and its perspective on managing ultra-high-cost drugs.

Q&A: NCPA Announces Independent Community Pharmacy Consortium for Government Engagement

Q&A: NCPA Announces Independent Community Pharmacy Consortium for Government Engagement

Brian Nowosielski;Kurt Proctor, PhD, RPh
January 21st 2025
Article

Kurt Proctor, PhD, RPh, President of the NCPA Innovation Center, discussed his organization’s efforts in launching the Independent Community Pharmacy Consortium for Government Engagement.

© 2025 MJH Life Sciences

All rights reserved.